Stay updated on Regorafenib after Sorafenib for Hepatocellular Carcinoma Clinical Trial

Sign up to get notified when there's something new on the Regorafenib after Sorafenib for Hepatocellular Carcinoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Regorafenib after Sorafenib for Hepatocellular Carcinoma Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    The website has been updated from version 2.14.0 to 2.14.1.
    Difference
    0.1%
    Check dated 2025-01-20T05:12:33.000Z thumbnail image
  2. Check
    12 days ago
    Change Detected
    Summary
    The website has updated the 'type of intervention' feature from version 2.13.3 to 2.14.0, indicating a significant change in this functionality.
    Difference
    0.2%
    Check dated 2025-01-13T00:25:39.000Z thumbnail image
  3. Check
    19 days ago
    No Change Detected
  4. Check
    26 days ago
    No Change Detected
  5. Check
    34 days ago
    No Change Detected
  6. Check
    41 days ago
    Change Detected
    Summary
    The website has been updated from version v2.13.2 to v2.13.3.
    Difference
    0.1%
    Check dated 2024-12-15T01:25:23.000Z thumbnail image
  7. Check
    48 days ago
    Change Detected
    Summary
    The website has updated the contact details section for the study, clarifying that it now provides information for individuals who can answer questions about joining the study, along with the location details.
    Difference
    2%
    Check dated 2024-12-07T23:10:43.000Z thumbnail image
  8. Check
    63 days ago
    Change Detected
    Summary
    The website has removed several links to external resources, including clinical trial registries and PubMed articles, which may affect access to relevant study information.
    Difference
    3%
    Check dated 2024-11-23T06:47:44.000Z thumbnail image
  9. Check
    70 days ago
    Change Detected
    Summary
    New resources related to Regorafenib and clinical trials have been added, including links to Dailymed, PubMed, and various government health websites.
    Difference
    0.3%
    Check dated 2024-11-16T02:55:52.000Z thumbnail image

Stay in the know with updates to Regorafenib after Sorafenib for Hepatocellular Carcinoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Regorafenib after Sorafenib for Hepatocellular Carcinoma Clinical Trial page.